The OBR Video Center Features educational videos covering a wide range of oncology specific topics.
Edward Li, PharmD, MPH, BCOP, Associate Professor, University of New England College of Pharmacy, discusses oncology targeting biosimilars that are nearing approval
Published: 04 May 2017
Nicolas Ferreyros, on the influence of pharmacy benefit managers
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, considers the influence of pharmacy benefit managers on the lives of cancer ...
Ira Klein, MD, MBA, FACP, on embracing value-based oncology care
Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., on embracing value-based ...
Nicolas Ferreyros, on what oncologists should know about their federal policymakers
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, offers opinion on what medical oncologists and practice administrators should know about ...
Ira Klein, MD, MBA, FACP, provides perspective on the rising cost of cancer drugs
Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., provides perspective on ...
Nicolas Ferreyros, explains why oncologists should communicate with their local representatives
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, explains why oncologists should communicate with their local representatives
Ira Klein, MD, MBA, FACP, on the role of value in cancer drug development
Dr. Klein, Senior Director, Healthcare Quality Strategy, Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., how value plays ...
Melissa Johnson, MD, shares her thoughts on biomarker development in NSCLC
Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, shares her thoughts on biomarker development in managing ...
Melissa Johnson, MD, speculates on exciting developments in the treatment of NSCLC
Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, tells us about some of the exciting new ...
Anshu Jain, MD, tells us what physicians & payers should know about proton therapy
Dr. Jain, Radiation Oncologist, COA Board Member, tells us what physicians and payers should know about proton therapy
Melissa Johnson, MD, on the updated NCCN guidelines in regards to PD-L1 testing
Dr. Johnson, Associate Director, Lung Cancer Research Program, Sarah Cannon Research Institute, elaborates on the recent updates to NCCN guidelines ...
Follow @OBRTweets